Some pharmacological or psychosocial interventions that enhance SorCS2 gene methylation may improve ADHD symptoms by interfering with the GMV reduction in the precentral and posterior orbital gyri. Here, SORCS2 is linked to attention deficit-hyperactivity disorder.